ACRL

Accrol Group Holdings Plc

35.40
0.30 (0.85%)
Share Name Share Symbol Market Type Share ISIN Share Description
Accrol Group Holdings Plc LSE:ACRL London Ordinary Share GB00BZ6VT592 ORD GBP0.001
  Price Change % Change Share Price Shares Traded Last Trade
  0.30 0.85% 35.40 216,808 16:35:19
Bid Price Offer Price High Price Low Price Open Price
34.30 35.60 35.70 34.60 35.70
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Convrt Paper,paperbd Pds,nec 159.45 -1.70 -0.50 - 112.88
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:19 UT 980 35.40 GBX

Accrol (ACRL) Latest News

Accrol (ACRL) Discussions and Chat

Accrol Forums and Chat

Date Time Title Posts
22/5/202319:52*** Accrol ***1,210
09/12/202011:03Accrol Papers (ACRL) Manufacturers of Soft Tissue Products3
20/6/201607:24Accrol Papers (ACRL) cleans up on AIM debut1

Add a New Thread

Accrol (ACRL) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Accrol (ACRL) Top Chat Posts

Top Posts
Posted at 17/5/2023 18:20 by blueball
Https://simplywall.st/stocks/gb/household/aim-acrl/accrol-group-holdings-shares

Trading 56% below fair value.

Posted at 15/5/2023 19:13 by darrin1471
The Q&A at 20:00 says ACRL will benefit on the "flipside" as prices fall. It is a minute long answer which I keep on going back to check.

https://vimeo.com/793456625/81fba09d3f

Posted at 15/5/2023 16:49 by darrin1471
chinahere. I hope it works out for us both. I am very overweight in ACRL.
Posted at 14/5/2023 20:57 by darrin1471
chinahere, Accrol have been growing by volume and revenue and going forward Gareth wants to use the existing diverse UK customer base to introduce new products.
Investment has been significant but input costs have been the big drag on profits over the last 18 months.
The immediate upside is the outlook in the year end update which as in-put prices fall will not only restore margins to normal levels but some price stickiness may lead to abnormally high margins. Although I would not expect them to shout this from the rooftops or customers will push through price reductions.
FY23/24 cash generation will be "quite profound" as capex on automation is complete and debt should fall rapidly. Debt guidance may be in the YE update or we may have to wait for the full update later in the year.
Looking at recent history, acquisitions may lead to additional debt or additional shares being issued if ACRL share price is at a much higher level.
Gareth has a M&A track record at DS Smith and that is where I see his ambitions being with ACRL. For that he will need a strong share price.

Posted at 13/5/2023 13:35 by darrin1471
Accrol investment case:
Accrol is currently my largest holding by some way on my belief that the FY23 end update due anytime soon (Tuesday 17/05/2022 LY) will give a very positive FY24 outlook.
Last years 17/05/2022 update included a year ahead outlook for revenue, EBITDA and PBT.
In the January webinar the board said:
1. ACRL will benefit from falling input prices like they lost out when the prices rose.
2. Cost of living crisis will have a positive impact on Accrol overall.
3. EBITDA in teens of revenue and gross margins back to normal which could be up to 30%.
4. FY23/24 cash generation will be "quite profound".
5. Accrol "ridiculously undervalued". If starting again today it would take £150m to buy current assets and 15 years to build UK customer base.
Https://vimeo.com/793456625/81fba09d3f
Gareth Jenkins appeared quite frustrated by the ACRL valuation as I think he wants a strong ACRL share price to back acquisition growth. Gareth has a business turnaround and M&A track record at DS Smith.
Https://www.accrol.co.uk/director/gareth-jenkins/
Currently there is a big gap between market expectations and the quoted ambition of EBITDA in teens and gross margins of up to 30%
It has been said that input paper costs are falling fast and kraft paper prices have fallen over 35% since January 10th.
Https://tradingeconomics.com/commodity/kraft-pulp
This could lead to lead to rapid margin improvement in H1 24 and could be reflected in the FY24 outlook due soon.
The appointment of Shore Capital in March as joint broker will hopefully increase Accrol exposure.

Posted at 04/5/2023 14:08 by darrin1471
Heads up, ACRL woke up.
Over 20 blocks of £50k buys today and on Tuesday paying as high as 37p a couple of minutes ago

Posted at 17/4/2023 20:41 by darrin1471
LSE are showing 4.8m ACRL traded today.
Large trades went through off book at 31.5p and auction ended at 32.7p

Https://www.londonstockexchange.com/stock/ACRL/accrol-group-holdings-plc/trade-recap

Posted at 27/1/2023 16:07 by darrin1471
From the webinar the most important thing for the short term is that ACRL will benefit from falling input prices like they lost out when the prices rose. Input prices are flat now and expected to fall.
Cost of living crisis will have a positive impact on Accrol overall.
EBITDA in teens of revenue and gross margins back to normal which could be up to 30%.
FY23/24 cash generation will be "quite profound".
Accrol "ridiculously undervalued". If starting again today it would take £150m to buy current assets and 15 years to build UK customer base.
Will consider spending cash generated on share buy back if share price remains undervalued.
Accrol biggest asset is their customer base as shown by John Dale acquisition. Future acquisitions should make use of the existing customer base rather than geographical expansion.

Mill will cost Accrol £10m including one machine, land and building (grants?). Not leasing building or machine. Expect multiple updates on progress soon and over coming months.

20% capacity available on toilet roll and kitchen towel.
Facial tissue can increase capacity from £20m to £30m with an investment of £1m
Wet wipes can double to £12m on existing lines and an investment of £3m over 3 years can increase capacity in the existing building to £40m

Posted at 26/1/2023 16:44 by darrin1471
One of the medium term concerns I had about ACRL was that the mill was going to be another drain on capital after the investment in automation and acquisitions.
So a total cash cost to the group of £10m seems very reasonable. I assume this must be for the land and building only and that the machinery would be leased?
ACRL said they "exited 2022 with 20% volume capacity to spare" and the mill will meet "40% of Accrol's expected annual tissue volume". So at current full capacity ACRL could run 3 machines. Is the £10m building unit big enough for just one machine or is there space to add more or would they need to extend?

Posted at 11/1/2023 20:12 by arbus5000
profitability should be coming to a point where a divi can be paid.

an FY23 ebit of 15mln against a mkap of 110mln, gives a P/E of just 7. I know that the market in general is underpriced, but Accrol is a growth stock valued as a value one. Market share, revenues are rising rapidly. Costs are on a downward trend.

Expect a re-rating 2-3 times current levels (i.e 70-100p), which would be bouyed by restatement of a divi. Having an inventory of reels is a sign of prudence and is the norm in the post pandemic world. We will have a better idea of the extent of this at the next results. Further bumps could be provided by a standard listing, and hence become eligible for passive funds.

Insider selling isn't always great news, but there wasn't any when the share price was in the 50's (to my recollection). The mngmt got significant incentive schemes when things looked bleaked a few years back (including some guy having his finger chopped off), but they have a right to take profits/optimise personal allocations.

Accrol is a bellwether stock for the UK economy and the markets in general, when its share price rises, things are good. When it falls, the rest of the markets get flushed. The exception to this was though, it was let down by covid, as the demand for loo paper was a red herring in terms of which way the markets were heading. Ultimatley the market recovered and then some, so perhaps was correct here too !

Accrol share price data is direct from the London Stock Exchange
Your Recent History
LSE
ACRL
Accrol
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230530 04:00:25